Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Jana Pelouchova






    Factors influencing adherence in CML and ways to improvement:
    Results from a patient-driven survey of 2,546 patients in 63 countries
    Jana Pelouchová, European Cancer Patient Coalition (ECPC), Czech Republic 

    • CML Advocates Network: Patients creating scientific evidence
    • Why this study?
    • Where are we now?
    • Truly global research: 2,546 patients from 63 countries
    • Validated adherence scales to classify patients into levels of adherence
    • Results on adherence levels
    • What can we do to drive adherence?
    • Conclusions